Smart Syringe Market Share, Trends, and Demand Forecast 2025-2033

IMARC Group’s report titled “Smart Syringe Market Report by Product (Auto-disable Syringes, Active Safety Syringes, Passive Safety Syringes), Age Group (Pediatrics, Adults), Application (Drug Delivery, Vaccination, Blood Specimen Collection), End User (Hospitals and HMOs, Diabetic Patients, Family Practices (Physicians), Psychiatrics, and Others), and Region 2025-2033“. The global smart syringe market size reached USD 10.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.1 Billion by 2033, exhibiting a growth rate (CAGR) of 6.30% during 2025-2033.

Factors Affecting the Growth of the Smart Syringe Industry:

● Increased Awareness of Needlestick Injuries:

Needlestick incidents pose a risk to healthcare workers, especially as they are prone to contracting infectious diseases such as HIV, hepatitis B and hepatitis C. Since these dangers are well known, there is a growing need for advanced safety medical devices such as smart syringes that prevent such incidents. The medical costs incurred during treatment of needlestick injuries, the cost of post-exposure prophylaxis for employees and the possibility of legal action have driven the adoption of smart syringes into costly healthcare facilities. This shift contributes as a solution to reducing the long-term effects of needlestick injuries.

● Growing Incidence of Chronic Diseases:

Diseases such as diabetes, arthritis and heart disease progress and inevitably require constant management using medication injections. As these diseases become increasingly common, the need for safe, effective and easy-to-use injection devices such as smart syringes has increased. For example, hearing and vaccination devices are used by patients to monitor and control their diseases at home or in hospitals. Smart syringes have been developed to improve patient safety through features such as auto disabling and administering doses.

● Technological Advancements:

Today's smart syringes also feature an auto-disable system that makes reuse unthinkable, which is very important in infection prevention. This technology ensures that the syringe cannot be used a second time, except by locking it; this is most useful in areas where reusing the same needle is a big problem. Advances in non-needle device delivery systems are a more effective and comfortable option for administering medications, making them very popular among patients and their caregivers.

Grab a sample PDF of this report: https://www.imarcgroup.com/smart-syringe-market/requestsample

Leading Companies Operating in the Global Smart Syringe Industry:

• AdvaCare Pharma
• B. Braun Melsungen AG
• Becton
• Dickinson and Company
• Gerresheimer AG
• Merit Medical Systems Inc.
• Nipro Corporation
• Numedico Technologies Pty Ltd.
• Retractable Technologies Inc.
• Terumo Corporation.

Smart Syringe Market Report Segmentation:

By Product:

• Auto-disable Syringes
• Active Safety Syringes
• Passive Safety Syringes

Active safety syringes represent the largest segment because they offer enhanced protection against needlestick injuries through mechanisms like retractable needles, making them highly preferred in clinical settings.

By Age Group:

• Pediatrics
• Adults

Adults account for the majority of the market share due to the higher prevalence of chronic diseases in this demographic, necessitating regular and safe medication administration.

By Application:

• Drug Delivery
• Vaccination
• Blood Specimen Collection

Drug delivery exhibits a clear dominance in the market as smart syringes are primarily used for precise and safe administration of medications, especially for chronic conditions.

By End User:

• Hospitals and HMOs
• Diabetic Patients
• Family Practices (Physicians)
• Psychiatrics
• Others

Hospitals and HMOs hold the biggest market share. Healthcare facilities are major purchasers of smart syringes to ensure safety and compliance with regulatory standards in patient care.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys the leading position in the smart syringe market owing to its advanced healthcare infrastructure, high awareness of needlestick injuries, and stringent safety regulations.

Global Smart Syringe Market Trends:

Increasing emphasis on healthcare worker safety and patient protection is driving the widespread adoption of smart syringes equipped with safety features like auto-disable mechanisms and retractable needles. With the rise in chronic diseases and the shift towards home-based care, there is an increasing demand for user-friendly smart syringes that enable patients to safely administer their own injections. Advancements in smart syringe technology, including the integration of digital features for dosage tracking and data connectivity, are enhancing the precision and usability of these devices, making them more attractive to healthcare providers.

Emerging economies are witnessing significant growth in the adoption of smart syringes due to increased healthcare spending, improved awareness of safety standards, and support from international health organizations.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145